Cargando…
Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease
BACKGROUND AND PURPOSE: Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin protein. We have previously demonstrated that the cell signalling of the metabotropic glutamate receptor 5 (mGluR5) is altered in a mouse m...
Autores principales: | Doria, JG, Silva, FR, Souza, JM, Vieira, LB, Carvalho, TG, Reis, HJ, Pereira, GS, Dobransky, T, Ribeiro, FM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687670/ https://www.ncbi.nlm.nih.gov/pubmed/23489026 http://dx.doi.org/10.1111/bph.12164 |
Ejemplares similares
-
Allosteric Molecular Switches in Metabotropic Glutamate Receptors
por: Orgován, Zoltán, et al.
Publicado: (2020) -
Metabotropic glutamate receptor 5 knockout rescues obesity phenotype in a mouse model of Huntington’s disease
por: Santos, Rebeca P. M., et al.
Publicado: (2022) -
Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2
por: Liauw, Brandon Wey-Hung, et al.
Publicado: (2022) -
Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease
por: Luessen, Deborah J., et al.
Publicado: (2022) -
Identification of Allosteric
Modulators of Metabotropic
Glutamate 7 Receptor Using Proteochemometric Modeling
por: Tresadern, Gary, et al.
Publicado: (2017)